pyrroles has been researched along with ginsenosides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheung, LW; Leung, KW; Wong, AS; Wong, CK; Wong, RN | 1 |
| Huang, MT; Lan, TH; Li, M; Song, JX; Wu, HL; Xu, DP | 1 |
2 other study(ies) available for pyrroles and ginsenosides
| Article | Year |
|---|---|
Ginsenoside-Rg1 induces angiogenesis via non-genomic crosstalk of glucocorticoid receptor and fibroblast growth factor receptor-1.
Topics: Angiogenesis Inducing Agents; Cells, Cultured; Endothelial Cells; Enzyme Activation; Ginsenosides; Hormone Antagonists; Humans; Mifepristone; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinase; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrroles; Receptor Cross-Talk; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Glucocorticoid; RNA Interference | 2011 |
Ginsenoside Rb1 prevents homocysteine-induced EPC dysfunction via VEGF/p38MAPK and SDF-1/CXCR4 activation.
Topics: Animals; Benzylamines; Cell Movement; Cell Survival; Chemokine CXCL12; Cyclams; Endothelial Progenitor Cells; Ginsenosides; Heterocyclic Compounds; Homocysteine; Indoles; Male; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyrroles; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2017 |